Michael Greenbaum

Safety and Effectiveness of Coadministration of Guanfacine Extended Release and Psychostimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

Thomas Spencer, Michael Greenbaum, Lawrence Ginsberg et al. · Journal of Child and Adolescent Psychopharmacology · 2009 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia

Calvin R. Sumner, Susan E. Gathercole, Michael Greenbaum et al. · Child and Adolescent Psychiatry and Mental Health · 2009 · 31 citations · Full text

Medicine, Pharmacotherapy, Special Education +17

Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study

Richard H. Weisler, Michael Greenbaum, Valerie Arnold et al. · CNS Drugs · 2017 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Atomoxetine Treatment in Adolescents with Attention-Deficit/Hyperactivity Disorder

Linda Wietecha, David W. Williams, Michael Herbert et al. · Journal of Child and Adolescent Psychopharmacology · 2009 · 21 citations

Medicine, Pharmacotherapy, Psychiatry +17

SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study

Matthew Brams, Ann Childress, Michael Greenbaum et al. · Journal of Child and Adolescent Psychopharmacology · 2017 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17